Zobrazeno 1 - 10
of 612
pro vyhledávání: '"Buxó M"'
Autor:
Marruecos Querol J; Radiation Oncology Department, Catalan Institute of Oncology, Girona, Spain. jmarruecos@iconcologia.net.; Research Group in Radiation Oncology and Medical Physics of Girona, Girona Biomedical Research Institute (IDIBGI), Girona, Spain. jmarruecos@iconcologia.net.; Department of Radiation Oncology, ICO, Girona, Spain. jmarruecos@iconcologia.net., Jurado-Bruggeman D; Research Group in Radiation Oncology and Medical Physics of Girona, Girona Biomedical Research Institute (IDIBGI), Girona, Spain.; Medical Physics and Radiation Protection Department, Catalan Institute of Oncology, Girona, Spain., Lopez-Vidal A; Medical Oncology Department, Catalan Institute of Oncology, Girona, Spain., Mesía Nin R; Medical Oncology Department, Catalan Institute of Oncology, B-ARGO Group, IGTP, Badalona, Spain., Rubió-Casadevall J; Medical Oncology Department, Catalan Institute of Oncology, Girona, Spain., Buxó M; Girona Biomedical Research Institute (IDIBGI), Girona, Spain., Eraso Urien A; Radiation Oncology Department, Catalan Institute of Oncology, Girona, Spain.; Research Group in Radiation Oncology and Medical Physics of Girona, Girona Biomedical Research Institute (IDIBGI), Girona, Spain.
Publikováno v:
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2024 Aug; Vol. 26 (8), pp. 1956-1967. Date of Electronic Publication: 2024 Mar 17.
Autor:
Ros-Buxó M; School of Medicine, Universitat de Barcelona, 08007 Barcelona, Spain., Mauro E; School of Medicine, Universitat de Barcelona, 08007 Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), 28029 Madrid, Spain.; Barcelona Clinic Liver Cancer (BCLC) Group, Liver Unit, Institut Clínic de Malalties Digestives i Metabòliques (ICMDM), Hospital Clinic Barcelona, 08036 Barcelona, Spain., Sauri T; School of Medicine, Universitat de Barcelona, 08007 Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain.; Barcelona Clinic Liver Cancer (BCLC) Group, Medical Oncology Department, Institut del Càncer i Malalties de la Sang (ICAMS), Hospital Clinic Barcelona, Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, 08036 Barcelona, Spain., Iserte G; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), 28029 Madrid, Spain.; Barcelona Clinic Liver Cancer (BCLC) Group, Liver Unit, Institut Clínic de Malalties Digestives i Metabòliques (ICMDM), Hospital Clinic Barcelona, 08036 Barcelona, Spain., Fuster-Anglada C; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), 28029 Madrid, Spain.; Barcelona Clinic Liver Cancer (BCLC) Group, Pathology Department, CDB, Hospital Clinic Barcelona, 08036 Barcelona, Spain., Díaz A; School of Medicine, Universitat de Barcelona, 08007 Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), 28029 Madrid, Spain.; Barcelona Clinic Liver Cancer (BCLC) Group, Pathology Department, CDB, Hospital Clinic Barcelona, 08036 Barcelona, Spain., Sererols-Viñas L; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain., Affo S; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain., Forner A; School of Medicine, Universitat de Barcelona, 08007 Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), 28029 Madrid, Spain.; Barcelona Clinic Liver Cancer (BCLC) Group, Liver Unit, Institut Clínic de Malalties Digestives i Metabòliques (ICMDM), Hospital Clinic Barcelona, 08036 Barcelona, Spain.
Publikováno v:
Current oncology (Toronto, Ont.) [Curr Oncol] 2024 Jun 21; Vol. 31 (7), pp. 3615-3629. Date of Electronic Publication: 2024 Jun 21.
Autor:
Gich J; Girona Neuroimmunology and Multiple Sclerosis Unit, Neurology Department, Dr. Josep Trueta University Hospital and Santa Caterina Hospital, Girona, Spain.; Neurodegeneration and Neuroinflammation Research Group, Girona Biomedical Research Institute (IDIBGI), Salt, Spain.; Department of Medical Sciences, Faculty of Medicine, University of Girona, Girona, Spain.; Faculty of Psychology and Educational Sciences, University of Girona, Girona, Spain., Salavedra-Pont J; Girona Neuroimmunology and Multiple Sclerosis Unit, Neurology Department, Dr. Josep Trueta University Hospital and Santa Caterina Hospital, Girona, Spain.; Neurodegeneration and Neuroinflammation Research Group, Girona Biomedical Research Institute (IDIBGI), Salt, Spain., Coll-Martinez C; Girona Neuroimmunology and Multiple Sclerosis Unit, Neurology Department, Dr. Josep Trueta University Hospital and Santa Caterina Hospital, Girona, Spain.; Neurodegeneration and Neuroinflammation Research Group, Girona Biomedical Research Institute (IDIBGI), Salt, Spain.; Redes de Investigación Cooperativa Orientada a Resultados en Salud (RICORS), Red de Enfermedades inflamatorias (RD21/0002/0063), Instituto de Salud Carlos III, Madrid, Spain., Quintana E; Neurodegeneration and Neuroinflammation Research Group, Girona Biomedical Research Institute (IDIBGI), Salt, Spain.; Department of Medical Sciences, Faculty of Medicine, University of Girona, Girona, Spain., Álvarez-Bravo G; Girona Neuroimmunology and Multiple Sclerosis Unit, Neurology Department, Dr. Josep Trueta University Hospital and Santa Caterina Hospital, Girona, Spain.; Neurodegeneration and Neuroinflammation Research Group, Girona Biomedical Research Institute (IDIBGI), Salt, Spain., Robles-Cedeño R; Girona Neuroimmunology and Multiple Sclerosis Unit, Neurology Department, Dr. Josep Trueta University Hospital and Santa Caterina Hospital, Girona, Spain.; Neurodegeneration and Neuroinflammation Research Group, Girona Biomedical Research Institute (IDIBGI), Salt, Spain.; Department of Medical Sciences, Faculty of Medicine, University of Girona, Girona, Spain.; Redes de Investigación Cooperativa Orientada a Resultados en Salud (RICORS), Red de Enfermedades inflamatorias (RD21/0002/0063), Instituto de Salud Carlos III, Madrid, Spain., Buxó M; Department of Statistics, Girona Biomedical Research Institute (IDIBGI), Salt, Spain., Contreras-Rodriguez O; Department of Medical Imaging, Girona Biomedical Research Institute (IDIBGI), Girona, Spain., Ramió-Torrentà L; Girona Neuroimmunology and Multiple Sclerosis Unit, Neurology Department, Dr. Josep Trueta University Hospital and Santa Caterina Hospital, Girona, Spain.; Neurodegeneration and Neuroinflammation Research Group, Girona Biomedical Research Institute (IDIBGI), Salt, Spain.; Department of Medical Sciences, Faculty of Medicine, University of Girona, Girona, Spain.; Redes de Investigación Cooperativa Orientada a Resultados en Salud (RICORS), Red de Enfermedades inflamatorias (RD21/0002/0063), Instituto de Salud Carlos III, Madrid, Spain.
Publikováno v:
Frontiers in psychology [Front Psychol] 2024 Jan 16; Vol. 14, pp. 1269794. Date of Electronic Publication: 2024 Jan 16 (Print Publication: 2023).
Autor:
Buxó, M. Jesús, Casado, María
Publikováno v:
In Gaceta Sanitaria September-October 2014 28(5):426-428
Autor:
Coll-Martinez C; Girona Neuroimmumology and Multiple Sclerosis Unit, Neurology Department, Dr. Josep Trueta University Hospital and Santa Caterina Hospital, Girona, Spain.; Neurodegeneration and Neuroinflammation Research Group, Girona Biomedical Research Institute (IDIBGI), Salt, Spain.; Redes de Investigación Cooperativa Orientada a Resultados en Salud (RICORS), Red de Enfermedades inflamatorias (RD21/0002/0063), Instituto de Salud Carlos III, Madrid, Spain., Salavedra-Pont J; Girona Neuroimmumology and Multiple Sclerosis Unit, Neurology Department, Dr. Josep Trueta University Hospital and Santa Caterina Hospital, Girona, Spain.; Neurodegeneration and Neuroinflammation Research Group, Girona Biomedical Research Institute (IDIBGI), Salt, Spain., Buxó M; Statistical Unit, Girona Biomedical Research Institute (IDIBGI), Salt, Spain., Quintana E; Neurodegeneration and Neuroinflammation Research Group, Girona Biomedical Research Institute (IDIBGI), Salt, Spain., Quiroga-Varela A; Neurodegeneration and Neuroinflammation Research Group, Girona Biomedical Research Institute (IDIBGI), Salt, Spain.; Redes de Investigación Cooperativa Orientada a Resultados en Salud (RICORS), Red de Enfermedades inflamatorias (RD21/0002/0063), Instituto de Salud Carlos III, Madrid, Spain., Robles-Cedeño R; Girona Neuroimmumology and Multiple Sclerosis Unit, Neurology Department, Dr. Josep Trueta University Hospital and Santa Caterina Hospital, Girona, Spain.; Neurodegeneration and Neuroinflammation Research Group, Girona Biomedical Research Institute (IDIBGI), Salt, Spain.; Redes de Investigación Cooperativa Orientada a Resultados en Salud (RICORS), Red de Enfermedades inflamatorias (RD21/0002/0063), Instituto de Salud Carlos III, Madrid, Spain.; Medical Sciences Department, University of Girona, Girona, Spain., Puig M; Girona Neuroimmumology and Multiple Sclerosis Unit, Neurology Department, Dr. Josep Trueta University Hospital and Santa Caterina Hospital, Girona, Spain.; Neurodegeneration and Neuroinflammation Research Group, Girona Biomedical Research Institute (IDIBGI), Salt, Spain., Álvarez-Bravo G; Girona Neuroimmumology and Multiple Sclerosis Unit, Neurology Department, Dr. Josep Trueta University Hospital and Santa Caterina Hospital, Girona, Spain.; Neurodegeneration and Neuroinflammation Research Group, Girona Biomedical Research Institute (IDIBGI), Salt, Spain., Ramió-Torrentà L; Girona Neuroimmumology and Multiple Sclerosis Unit, Neurology Department, Dr. Josep Trueta University Hospital and Santa Caterina Hospital, Girona, Spain.; Neurodegeneration and Neuroinflammation Research Group, Girona Biomedical Research Institute (IDIBGI), Salt, Spain.; Redes de Investigación Cooperativa Orientada a Resultados en Salud (RICORS), Red de Enfermedades inflamatorias (RD21/0002/0063), Instituto de Salud Carlos III, Madrid, Spain.; Medical Sciences Department, University of Girona, Girona, Spain., Gich J; Girona Neuroimmumology and Multiple Sclerosis Unit, Neurology Department, Dr. Josep Trueta University Hospital and Santa Caterina Hospital, Girona, Spain.; Neurodegeneration and Neuroinflammation Research Group, Girona Biomedical Research Institute (IDIBGI), Salt, Spain.; Medical Sciences Department, University of Girona, Girona, Spain.
Publikováno v:
Frontiers in psychology [Front Psychol] 2023 Aug 23; Vol. 14, pp. 1163112. Date of Electronic Publication: 2023 Aug 23 (Print Publication: 2023).
Autor:
Marruecos-Querol J; Radiation Oncology Department, Catalan Institute of Oncology, ICO Girona, Girona, Spain. jmarruecos@iconcologia.net., Rubió-Casadevall J; Medical Oncology Department, Catalan Institute of Oncology, Girona, Spain., Lozano A; Radiation Oncology Department, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Barcelona, Spain., Buxó M; Girona Biomedical Research Institute (IDIBGI), Girona, Spain., Puigdemont M; Epidemiology Unit and Girona Cancer Registry, Descriptive Epidemiology, Genetics and Cancer Prevention Group, IDIBGI, Catalan Institute of Oncology, Girona, Spain., Linares I; Radiation Oncology Department, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Barcelona, Spain., Planas I; Radiation Oncology Department, Catalan Institute of Oncology, Badalona, Spain., Vayreda J; Radiation Oncology Department, Catalan Institute of Oncology, ICO Girona, Girona, Spain., Cirauqui B; Medical Oncology Department, Catalan Institute of Oncology, Badalona, Spain., Taberna M; Medical Oncology Department, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Barcelona, Spain., Quiroga V; Medical Oncology Department, Catalan Institute of Oncology, Badalona, Spain., Tobed M; Otorhinolaryngology Department, Dr. Trueta Hospital, Girona, Spain., Borés A; Otorhinolaryngology Department, Dr. Trueta Hospital, Girona, Spain., Recalde S; Medical Oncology Department, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Barcelona, Spain., Saigi M; Medical Oncology Department, Catalan Institute of Oncology, Badalona, Spain., Felip E; Medical Oncology Department, Catalan Institute of Oncology, Badalona, Spain., Eraso A; Radiation Oncology Department, Catalan Institute of Oncology, ICO Girona, Girona, Spain., Mesía R; Medical Oncology Department, Catalan Institute of Oncology, Badalona, Spain.
Publikováno v:
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2023 Aug; Vol. 25 (8), pp. 2384-2392. Date of Electronic Publication: 2023 Mar 21.
Autor:
Sojo L; Department of Diabetes, Endocrinology and Nutrition, Dr. Josep Trueta Hospital, 17007 Girona, Spain.; Girona Biomedical Research Institute (IDIBGI), 17007 Girona, Spain., Santos-González E; Department of Diabetes, Endocrinology and Nutrition, Dr. Josep Trueta Hospital, 17007 Girona, Spain.; Girona Biomedical Research Institute (IDIBGI), 17007 Girona, Spain.; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), 28029 Madrid, Spain., Riera L; Department of Diabetes, Endocrinology and Nutrition, Dr. Josep Trueta Hospital, 17007 Girona, Spain., Aguilera A; Department of Diabetes, Endocrinology and Nutrition, Dr. Josep Trueta Hospital, 17007 Girona, Spain.; Girona Biomedical Research Institute (IDIBGI), 17007 Girona, Spain.; Department of Medical Sciences, School of Medicine, 17003 Girona, Spain., Barahona R; Department of Diabetes, Endocrinology and Nutrition, Dr. Josep Trueta Hospital, 17007 Girona, Spain.; Girona Biomedical Research Institute (IDIBGI), 17007 Girona, Spain.; Department of Medical Sciences, School of Medicine, 17003 Girona, Spain., Pellicer P; Department of Diabetes, Endocrinology and Nutrition, Dr. Josep Trueta Hospital, 17007 Girona, Spain., Buxó M; Girona Biomedical Research Institute (IDIBGI), 17007 Girona, Spain., Mayneris-Perxachs J; Department of Diabetes, Endocrinology and Nutrition, Dr. Josep Trueta Hospital, 17007 Girona, Spain.; Girona Biomedical Research Institute (IDIBGI), 17007 Girona, Spain.; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), 28029 Madrid, Spain., Fernandez-Balsells M; Department of Diabetes, Endocrinology and Nutrition, Dr. Josep Trueta Hospital, 17007 Girona, Spain.; Girona Biomedical Research Institute (IDIBGI), 17007 Girona, Spain.; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), 28029 Madrid, Spain.; Department of Medical Sciences, School of Medicine, 17003 Girona, Spain., Fernández-Real JM; Department of Diabetes, Endocrinology and Nutrition, Dr. Josep Trueta Hospital, 17007 Girona, Spain.; Girona Biomedical Research Institute (IDIBGI), 17007 Girona, Spain.; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), 28029 Madrid, Spain.; Department of Medical Sciences, School of Medicine, 17003 Girona, Spain.
Publikováno v:
Antioxidants (Basel, Switzerland) [Antioxidants (Basel)] 2023 May 20; Vol. 12 (5). Date of Electronic Publication: 2023 May 20.
Autor:
Terceño M; Stroke Unit, Department of Neurology, Hospital Universitari Doctor Josep Trueta de Girona, Girona, Spain.; Cerebrovascular Pathology Research Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain., Bashir S; Stroke Unit, Department of Neurology, Hospital Universitari Doctor Josep Trueta de Girona, Girona, Spain.; Cerebrovascular Pathology Research Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain., Cienfuegos J; Stroke Unit, Department of Neurology, Hospital Universitari Doctor Josep Trueta de Girona, Girona, Spain.; Cerebrovascular Pathology Research Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain., Murillo A; Stroke Unit, Department of Neurology, Hospital Universitari Doctor Josep Trueta de Girona, Girona, Spain.; Cerebrovascular Pathology Research Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain., Vera-Monge VA; Stroke Unit, Department of Neurology, Hospital Universitari Doctor Josep Trueta de Girona, Girona, Spain.; Cerebrovascular Pathology Research Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain., Pardo L; Stroke Unit, Department of Neurology, Hospital Universitari Doctor Josep Trueta de Girona, Girona, Spain.; Cerebrovascular Pathology Research Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain., Reina M; Stroke Unit, Department of Neurology, Hospital Universitari Doctor Josep Trueta de Girona, Girona, Spain.; Cerebrovascular Pathology Research Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain., Gubern-Mérida C; Stroke Unit, Department of Neurology, Hospital Universitari Doctor Josep Trueta de Girona, Girona, Spain.; Cerebrovascular Pathology Research Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain., Puigoriol-Illamola D; Stroke Unit, Department of Neurology, Hospital Universitari Doctor Josep Trueta de Girona, Girona, Spain.; Cerebrovascular Pathology Research Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain., Carballo L; Stroke Unit, Department of Neurology, Hospital Universitari Doctor Josep Trueta de Girona, Girona, Spain.; Cerebrovascular Pathology Research Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain., Costa A; Department of Anesthesiology and Critical Care Medicine, Hospital Universitari Doctor Josep Trueta de Girona, Girona, Spain., Buxó M; Statistical and Methodological Department, Girona Biomedical Research Institute (IDIBGI), Girona, Spain., Serena J; Stroke Unit, Department of Neurology, Hospital Universitari Doctor Josep Trueta de Girona, Girona, Spain.; Cerebrovascular Pathology Research Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain., Silva Y; Stroke Unit, Department of Neurology, Hospital Universitari Doctor Josep Trueta de Girona, Girona, Spain.; Cerebrovascular Pathology Research Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain.
Publikováno v:
European stroke journal [Eur Stroke J] 2023 Mar; Vol. 8 (1), pp. 85-92. Date of Electronic Publication: 2022 Oct 13.
Autor:
Clèries R; Pla Director d'Oncología, Av Gran Vía 199-203, 08908 L'Hospitalet de Llobregat, Barcelona, Spain.; Bellvitge Biomedical Research Institute, IDIBELL, Av. Gran Via de l'Hospitalet, 199-203-1a planta, 08908 L'Hospitalet de Llobregat, Barcelona, Spain.; Clinical Sciences Department, Universitat de Barcelona, 08907 Barcelona, Spain., Ameijide A; Tarragona Cancer Registry, Epidemiology and Cancer Prevention Service, Hospital Universitari Sant Joan de Reus, IISPV, 43204 Reus, Spain., Buxó M; Girona Biomedical Research Institute, IDIBGI, C/Dr. Castany s/n, Edifici M2, Parc Hospitalari Martí i Julià, 17190 Salt, Spain., Vilardell M; Independent Researcher, 08700 Barcelona, Spain., Martínez JM; Statistics and Operational Research Department, Universitat Politècnica de Catalunya, EDIFICI H, Diagonal 647, 08028 Barcelona, Spain.; Public Health Research Group, University of Alicante, 03690 Alicante, Spain., Font R; Pla Director d'Oncología, Av Gran Vía 199-203, 08908 L'Hospitalet de Llobregat, Barcelona, Spain.; Bellvitge Biomedical Research Institute, IDIBELL, Av. Gran Via de l'Hospitalet, 199-203-1a planta, 08908 L'Hospitalet de Llobregat, Barcelona, Spain., Marcos-Gragera R; Girona Biomedical Research Institute, IDIBGI, C/Dr. Castany s/n, Edifici M2, Parc Hospitalari Martí i Julià, 17190 Salt, Spain.; Girona Cancer Registry, Epidemiology Unit, Pla Director d'Oncologia, Institut Català d'Oncología, Group for Descriptive Epidemiology, Genetics and Cancer Prevention, Girona-IDIBGI, 17005 Girona, Spain.; Medical School, Universitat de Girona (UdG), 17071 Girona, Spain.; Epidemiology and Public Health Research Network Centre (CIBERESP), 28029 Madrid, Spain., Puigdemont M; Girona Cancer Registry, Epidemiology Unit, Pla Director d'Oncologia, Institut Català d'Oncología, Group for Descriptive Epidemiology, Genetics and Cancer Prevention, Girona-IDIBGI, 17005 Girona, Spain., Viñas G; Medical Oncology Service, Catalan Institute of Oncology, Hospital Universitari de Girona 'Doctor Josep Trueta', 17005 Girona, Spain., Carulla M; Tarragona Cancer Registry, Epidemiology and Cancer Prevention Service, Hospital Universitari Sant Joan de Reus, IISPV, 43204 Reus, Spain., Espinàs JA; Pla Director d'Oncología, Av Gran Vía 199-203, 08908 L'Hospitalet de Llobregat, Barcelona, Spain.; Bellvitge Biomedical Research Institute, IDIBELL, Av. Gran Via de l'Hospitalet, 199-203-1a planta, 08908 L'Hospitalet de Llobregat, Barcelona, Spain., Galceran J; Tarragona Cancer Registry, Epidemiology and Cancer Prevention Service, Hospital Universitari Sant Joan de Reus, IISPV, 43204 Reus, Spain., Izquierdo Á; Girona Cancer Registry, Epidemiology Unit, Pla Director d'Oncologia, Institut Català d'Oncología, Group for Descriptive Epidemiology, Genetics and Cancer Prevention, Girona-IDIBGI, 17005 Girona, Spain.; Medical Oncology Service, Catalan Institute of Oncology, Hospital Universitari de Girona 'Doctor Josep Trueta', 17005 Girona, Spain., Borràs JM; Pla Director d'Oncología, Av Gran Vía 199-203, 08908 L'Hospitalet de Llobregat, Barcelona, Spain.; Bellvitge Biomedical Research Institute, IDIBELL, Av. Gran Via de l'Hospitalet, 199-203-1a planta, 08908 L'Hospitalet de Llobregat, Barcelona, Spain.; Clinical Sciences Department, Universitat de Barcelona, 08907 Barcelona, Spain.
Publikováno v:
International journal of environmental research and public health [Int J Environ Res Public Health] 2022 Dec 27; Vol. 20 (1). Date of Electronic Publication: 2022 Dec 27.
Autor:
Muñoz-San Martín M; From the Neuroinflammation and Neurodegeneration Group (M.M.-S.M., I.G., A.Q.-V., M.G.R., R.R.C., G.Á., A.M., E.Q., L.R.-T.), Girona Biomedical Research Institute (IDIBGI), Salt, Spain; CERCA Programme/Generalitat de Catalunya; Neurology Department (R.R.C., G.Á., L.R.-T.), Girona Neuroimmunology and Multiple Sclerosis Unit, Dr. Josep Trueta University Hospital and Santa Caterina Hospital; Red Española de Esclerosis Múltiple (REEM) (R.R.C., E.Q., L.R.-T.) Medical Sciences Department (R.R.C., E.Q., L.R.-T.), University of Girona (UdG), Spain; Girona Biomedical Research Institute (IDIBGI) (M.B.), Spain; Immunology Department (L.M.V.), Hospital Ramón y Cajal, Madrid, Spain; IRYCIS; and Unitat de Neuroimmunologia, Hospital Universitari i Politècnic La Fe.València (J.C.-V., B.C.)., Gómez I; From the Neuroinflammation and Neurodegeneration Group (M.M.-S.M., I.G., A.Q.-V., M.G.R., R.R.C., G.Á., A.M., E.Q., L.R.-T.), Girona Biomedical Research Institute (IDIBGI), Salt, Spain; CERCA Programme/Generalitat de Catalunya; Neurology Department (R.R.C., G.Á., L.R.-T.), Girona Neuroimmunology and Multiple Sclerosis Unit, Dr. Josep Trueta University Hospital and Santa Caterina Hospital; Red Española de Esclerosis Múltiple (REEM) (R.R.C., E.Q., L.R.-T.) Medical Sciences Department (R.R.C., E.Q., L.R.-T.), University of Girona (UdG), Spain; Girona Biomedical Research Institute (IDIBGI) (M.B.), Spain; Immunology Department (L.M.V.), Hospital Ramón y Cajal, Madrid, Spain; IRYCIS; and Unitat de Neuroimmunologia, Hospital Universitari i Politècnic La Fe.València (J.C.-V., B.C.)., Quiroga-Varela A; From the Neuroinflammation and Neurodegeneration Group (M.M.-S.M., I.G., A.Q.-V., M.G.R., R.R.C., G.Á., A.M., E.Q., L.R.-T.), Girona Biomedical Research Institute (IDIBGI), Salt, Spain; CERCA Programme/Generalitat de Catalunya; Neurology Department (R.R.C., G.Á., L.R.-T.), Girona Neuroimmunology and Multiple Sclerosis Unit, Dr. Josep Trueta University Hospital and Santa Caterina Hospital; Red Española de Esclerosis Múltiple (REEM) (R.R.C., E.Q., L.R.-T.) Medical Sciences Department (R.R.C., E.Q., L.R.-T.), University of Girona (UdG), Spain; Girona Biomedical Research Institute (IDIBGI) (M.B.), Spain; Immunology Department (L.M.V.), Hospital Ramón y Cajal, Madrid, Spain; IRYCIS; and Unitat de Neuroimmunologia, Hospital Universitari i Politècnic La Fe.València (J.C.-V., B.C.)., Gonzalez-Del Río M; From the Neuroinflammation and Neurodegeneration Group (M.M.-S.M., I.G., A.Q.-V., M.G.R., R.R.C., G.Á., A.M., E.Q., L.R.-T.), Girona Biomedical Research Institute (IDIBGI), Salt, Spain; CERCA Programme/Generalitat de Catalunya; Neurology Department (R.R.C., G.Á., L.R.-T.), Girona Neuroimmunology and Multiple Sclerosis Unit, Dr. Josep Trueta University Hospital and Santa Caterina Hospital; Red Española de Esclerosis Múltiple (REEM) (R.R.C., E.Q., L.R.-T.) Medical Sciences Department (R.R.C., E.Q., L.R.-T.), University of Girona (UdG), Spain; Girona Biomedical Research Institute (IDIBGI) (M.B.), Spain; Immunology Department (L.M.V.), Hospital Ramón y Cajal, Madrid, Spain; IRYCIS; and Unitat de Neuroimmunologia, Hospital Universitari i Politècnic La Fe.València (J.C.-V., B.C.)., Robles Cedeño R; From the Neuroinflammation and Neurodegeneration Group (M.M.-S.M., I.G., A.Q.-V., M.G.R., R.R.C., G.Á., A.M., E.Q., L.R.-T.), Girona Biomedical Research Institute (IDIBGI), Salt, Spain; CERCA Programme/Generalitat de Catalunya; Neurology Department (R.R.C., G.Á., L.R.-T.), Girona Neuroimmunology and Multiple Sclerosis Unit, Dr. Josep Trueta University Hospital and Santa Caterina Hospital; Red Española de Esclerosis Múltiple (REEM) (R.R.C., E.Q., L.R.-T.) Medical Sciences Department (R.R.C., E.Q., L.R.-T.), University of Girona (UdG), Spain; Girona Biomedical Research Institute (IDIBGI) (M.B.), Spain; Immunology Department (L.M.V.), Hospital Ramón y Cajal, Madrid, Spain; IRYCIS; and Unitat de Neuroimmunologia, Hospital Universitari i Politècnic La Fe.València (J.C.-V., B.C.)., Álvarez G; From the Neuroinflammation and Neurodegeneration Group (M.M.-S.M., I.G., A.Q.-V., M.G.R., R.R.C., G.Á., A.M., E.Q., L.R.-T.), Girona Biomedical Research Institute (IDIBGI), Salt, Spain; CERCA Programme/Generalitat de Catalunya; Neurology Department (R.R.C., G.Á., L.R.-T.), Girona Neuroimmunology and Multiple Sclerosis Unit, Dr. Josep Trueta University Hospital and Santa Caterina Hospital; Red Española de Esclerosis Múltiple (REEM) (R.R.C., E.Q., L.R.-T.) Medical Sciences Department (R.R.C., E.Q., L.R.-T.), University of Girona (UdG), Spain; Girona Biomedical Research Institute (IDIBGI) (M.B.), Spain; Immunology Department (L.M.V.), Hospital Ramón y Cajal, Madrid, Spain; IRYCIS; and Unitat de Neuroimmunologia, Hospital Universitari i Politècnic La Fe.València (J.C.-V., B.C.)., Buxó M; From the Neuroinflammation and Neurodegeneration Group (M.M.-S.M., I.G., A.Q.-V., M.G.R., R.R.C., G.Á., A.M., E.Q., L.R.-T.), Girona Biomedical Research Institute (IDIBGI), Salt, Spain; CERCA Programme/Generalitat de Catalunya; Neurology Department (R.R.C., G.Á., L.R.-T.), Girona Neuroimmunology and Multiple Sclerosis Unit, Dr. Josep Trueta University Hospital and Santa Caterina Hospital; Red Española de Esclerosis Múltiple (REEM) (R.R.C., E.Q., L.R.-T.) Medical Sciences Department (R.R.C., E.Q., L.R.-T.), University of Girona (UdG), Spain; Girona Biomedical Research Institute (IDIBGI) (M.B.), Spain; Immunology Department (L.M.V.), Hospital Ramón y Cajal, Madrid, Spain; IRYCIS; and Unitat de Neuroimmunologia, Hospital Universitari i Politècnic La Fe.València (J.C.-V., B.C.)., Miguela A; From the Neuroinflammation and Neurodegeneration Group (M.M.-S.M., I.G., A.Q.-V., M.G.R., R.R.C., G.Á., A.M., E.Q., L.R.-T.), Girona Biomedical Research Institute (IDIBGI), Salt, Spain; CERCA Programme/Generalitat de Catalunya; Neurology Department (R.R.C., G.Á., L.R.-T.), Girona Neuroimmunology and Multiple Sclerosis Unit, Dr. Josep Trueta University Hospital and Santa Caterina Hospital; Red Española de Esclerosis Múltiple (REEM) (R.R.C., E.Q., L.R.-T.) Medical Sciences Department (R.R.C., E.Q., L.R.-T.), University of Girona (UdG), Spain; Girona Biomedical Research Institute (IDIBGI) (M.B.), Spain; Immunology Department (L.M.V.), Hospital Ramón y Cajal, Madrid, Spain; IRYCIS; and Unitat de Neuroimmunologia, Hospital Universitari i Politècnic La Fe.València (J.C.-V., B.C.)., Villar LM; From the Neuroinflammation and Neurodegeneration Group (M.M.-S.M., I.G., A.Q.-V., M.G.R., R.R.C., G.Á., A.M., E.Q., L.R.-T.), Girona Biomedical Research Institute (IDIBGI), Salt, Spain; CERCA Programme/Generalitat de Catalunya; Neurology Department (R.R.C., G.Á., L.R.-T.), Girona Neuroimmunology and Multiple Sclerosis Unit, Dr. Josep Trueta University Hospital and Santa Caterina Hospital; Red Española de Esclerosis Múltiple (REEM) (R.R.C., E.Q., L.R.-T.) Medical Sciences Department (R.R.C., E.Q., L.R.-T.), University of Girona (UdG), Spain; Girona Biomedical Research Institute (IDIBGI) (M.B.), Spain; Immunology Department (L.M.V.), Hospital Ramón y Cajal, Madrid, Spain; IRYCIS; and Unitat de Neuroimmunologia, Hospital Universitari i Politècnic La Fe.València (J.C.-V., B.C.)., Castillo-Villalba J; From the Neuroinflammation and Neurodegeneration Group (M.M.-S.M., I.G., A.Q.-V., M.G.R., R.R.C., G.Á., A.M., E.Q., L.R.-T.), Girona Biomedical Research Institute (IDIBGI), Salt, Spain; CERCA Programme/Generalitat de Catalunya; Neurology Department (R.R.C., G.Á., L.R.-T.), Girona Neuroimmunology and Multiple Sclerosis Unit, Dr. Josep Trueta University Hospital and Santa Caterina Hospital; Red Española de Esclerosis Múltiple (REEM) (R.R.C., E.Q., L.R.-T.) Medical Sciences Department (R.R.C., E.Q., L.R.-T.), University of Girona (UdG), Spain; Girona Biomedical Research Institute (IDIBGI) (M.B.), Spain; Immunology Department (L.M.V.), Hospital Ramón y Cajal, Madrid, Spain; IRYCIS; and Unitat de Neuroimmunologia, Hospital Universitari i Politècnic La Fe.València (J.C.-V., B.C.)., Casanova B; From the Neuroinflammation and Neurodegeneration Group (M.M.-S.M., I.G., A.Q.-V., M.G.R., R.R.C., G.Á., A.M., E.Q., L.R.-T.), Girona Biomedical Research Institute (IDIBGI), Salt, Spain; CERCA Programme/Generalitat de Catalunya; Neurology Department (R.R.C., G.Á., L.R.-T.), Girona Neuroimmunology and Multiple Sclerosis Unit, Dr. Josep Trueta University Hospital and Santa Caterina Hospital; Red Española de Esclerosis Múltiple (REEM) (R.R.C., E.Q., L.R.-T.) Medical Sciences Department (R.R.C., E.Q., L.R.-T.), University of Girona (UdG), Spain; Girona Biomedical Research Institute (IDIBGI) (M.B.), Spain; Immunology Department (L.M.V.), Hospital Ramón y Cajal, Madrid, Spain; IRYCIS; and Unitat de Neuroimmunologia, Hospital Universitari i Politècnic La Fe.València (J.C.-V., B.C.)., Quintana E; From the Neuroinflammation and Neurodegeneration Group (M.M.-S.M., I.G., A.Q.-V., M.G.R., R.R.C., G.Á., A.M., E.Q., L.R.-T.), Girona Biomedical Research Institute (IDIBGI), Salt, Spain; CERCA Programme/Generalitat de Catalunya; Neurology Department (R.R.C., G.Á., L.R.-T.), Girona Neuroimmunology and Multiple Sclerosis Unit, Dr. Josep Trueta University Hospital and Santa Caterina Hospital; Red Española de Esclerosis Múltiple (REEM) (R.R.C., E.Q., L.R.-T.) Medical Sciences Department (R.R.C., E.Q., L.R.-T.), University of Girona (UdG), Spain; Girona Biomedical Research Institute (IDIBGI) (M.B.), Spain; Immunology Department (L.M.V.), Hospital Ramón y Cajal, Madrid, Spain; IRYCIS; and Unitat de Neuroimmunologia, Hospital Universitari i Politècnic La Fe.València (J.C.-V., B.C.). llramio@idibgi.org equintana@idibgi.org., Ramió-Torrentà L; From the Neuroinflammation and Neurodegeneration Group (M.M.-S.M., I.G., A.Q.-V., M.G.R., R.R.C., G.Á., A.M., E.Q., L.R.-T.), Girona Biomedical Research Institute (IDIBGI), Salt, Spain; CERCA Programme/Generalitat de Catalunya; Neurology Department (R.R.C., G.Á., L.R.-T.), Girona Neuroimmunology and Multiple Sclerosis Unit, Dr. Josep Trueta University Hospital and Santa Caterina Hospital; Red Española de Esclerosis Múltiple (REEM) (R.R.C., E.Q., L.R.-T.) Medical Sciences Department (R.R.C., E.Q., L.R.-T.), University of Girona (UdG), Spain; Girona Biomedical Research Institute (IDIBGI) (M.B.), Spain; Immunology Department (L.M.V.), Hospital Ramón y Cajal, Madrid, Spain; IRYCIS; and Unitat de Neuroimmunologia, Hospital Universitari i Politècnic La Fe.València (J.C.-V., B.C.). llramio@idibgi.org equintana@idibgi.org.
Publikováno v:
Neurology(R) neuroimmunology & neuroinflammation [Neurol Neuroimmunol Neuroinflamm] 2022 Dec 09; Vol. 10 (1). Date of Electronic Publication: 2022 Dec 09 (Print Publication: 2023).